OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Efficacy and tolerability of perampanel in children and adolescents with pharmacoresistant epilepsy: The first real-world evaluation in Asian pediatric neurology clinics
Kuang‐Lin Lin, Jainn‐Jim Lin, Ming-Liang Chou, et al.
Epilepsy & Behavior (2018) Vol. 85, pp. 188-194
Open Access | Times Cited: 62
Kuang‐Lin Lin, Jainn‐Jim Lin, Ming-Liang Chou, et al.
Epilepsy & Behavior (2018) Vol. 85, pp. 188-194
Open Access | Times Cited: 62
Showing 1-25 of 62 citing articles:
Psychobehavioural and Cognitive Adverse Events of Anti-Seizure Medications for the Treatment of Developmental and Epileptic Encephalopathies
Adam Strzelczyk, Susanne Schubert‐Bast
CNS Drugs (2022) Vol. 36, Iss. 10, pp. 1079-1111
Open Access | Times Cited: 92
Adam Strzelczyk, Susanne Schubert‐Bast
CNS Drugs (2022) Vol. 36, Iss. 10, pp. 1079-1111
Open Access | Times Cited: 92
The efficacy of perampanel in young children with drug-resistant epilepsy
Fu-Man Chang, Pi‐Chuan Fan, Wen‐Chin Weng, et al.
Seizure (2019) Vol. 75, pp. 82-86
Open Access | Times Cited: 56
Fu-Man Chang, Pi‐Chuan Fan, Wen‐Chin Weng, et al.
Seizure (2019) Vol. 75, pp. 82-86
Open Access | Times Cited: 56
Efficacy and tolerability of perampanel as a first add-on therapy with different anti-seizure drugs
Estevo Santamarina, V Bertol, Vanesa Garayoa, et al.
Seizure (2020) Vol. 83, pp. 48-56
Open Access | Times Cited: 43
Estevo Santamarina, V Bertol, Vanesa Garayoa, et al.
Seizure (2020) Vol. 83, pp. 48-56
Open Access | Times Cited: 43
Kainate Receptor Antagonists: Recent Advances and Therapeutic Perspective
Paulina Chałupnik, Ewa Szymańska
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 3, pp. 1908-1908
Open Access | Times Cited: 15
Paulina Chałupnik, Ewa Szymańska
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 3, pp. 1908-1908
Open Access | Times Cited: 15
Effectiveness and safety of perampanel for pediatric patients with epilepsy: A real‐world study from China
Xiaohui Wang, Taoyun Ji, Maomao Liu, et al.
Pediatric Investigation (2025)
Open Access
Xiaohui Wang, Taoyun Ji, Maomao Liu, et al.
Pediatric Investigation (2025)
Open Access
Efficacy and tolerability of perampanel in pediatric patients with Dravet syndrome
Shinsaku Yoshitomi, Yukitoshi Takahashi, Tokito Yamaguchi, et al.
Epilepsy Research (2019) Vol. 154, pp. 34-38
Closed Access | Times Cited: 33
Shinsaku Yoshitomi, Yukitoshi Takahashi, Tokito Yamaguchi, et al.
Epilepsy Research (2019) Vol. 154, pp. 34-38
Closed Access | Times Cited: 33
Efficacy and adverse reactions of perampanel in the treatment of epilepsy in children
Dan Li, Shaoping Huang, Yuqin Wang, et al.
Frontiers in Neurology (2022) Vol. 13
Open Access | Times Cited: 16
Dan Li, Shaoping Huang, Yuqin Wang, et al.
Frontiers in Neurology (2022) Vol. 13
Open Access | Times Cited: 16
Effectiveness and safety of perampanel as adjunctive therapy among Chinese patients with focal-onset epilepsy: A real-world prospective observational study
Qinyue Wang, Ye Xu, Yuncan Chen, et al.
Epilepsy & Behavior (2022) Vol. 136, pp. 108937-108937
Open Access | Times Cited: 16
Qinyue Wang, Ye Xu, Yuncan Chen, et al.
Epilepsy & Behavior (2022) Vol. 136, pp. 108937-108937
Open Access | Times Cited: 16
Clinical profiles associated with serum perampanel concentrations in children with refractory epilepsy
Nobutsune Ishikawa, Yuichi Tateishi, Hiroo Tani, et al.
Epilepsy & Behavior (2019) Vol. 94, pp. 82-86
Closed Access | Times Cited: 28
Nobutsune Ishikawa, Yuichi Tateishi, Hiroo Tani, et al.
Epilepsy & Behavior (2019) Vol. 94, pp. 82-86
Closed Access | Times Cited: 28
Recent advances in the pharmacotherapy of epilepsy: brivaracetam and perampanel as broad-spectrum antiseizure drugs for the treatment of epilepsies and status epilepticus
Laurent M. Willems, Sebastian Bauer, Felix Rosenow, et al.
Expert Opinion on Pharmacotherapy (2019) Vol. 20, Iss. 14, pp. 1755-1765
Closed Access | Times Cited: 27
Laurent M. Willems, Sebastian Bauer, Felix Rosenow, et al.
Expert Opinion on Pharmacotherapy (2019) Vol. 20, Iss. 14, pp. 1755-1765
Closed Access | Times Cited: 27
Movement disorders associated with antiseizure medications: A systematic review
Daniel J. Zhou, Spriha Pavuluri, Isha Snehal, et al.
Epilepsy & Behavior (2022) Vol. 131, pp. 108693-108693
Open Access | Times Cited: 15
Daniel J. Zhou, Spriha Pavuluri, Isha Snehal, et al.
Epilepsy & Behavior (2022) Vol. 131, pp. 108693-108693
Open Access | Times Cited: 15
Efficacy of perampanel as an adjunctive therapy in pediatric focal epilepsy
Weiran Zhang, Liu Liu, Chaofu Lu, et al.
World Journal of Pediatrics (2023)
Open Access | Times Cited: 7
Weiran Zhang, Liu Liu, Chaofu Lu, et al.
World Journal of Pediatrics (2023)
Open Access | Times Cited: 7
Efficacy, tolerability and safety of perampanel in children and adolescents with epilepsy: Systematic review and meta-analysis
Sujuan Sun, Xiangliang Li, Xuewu Liu
Brain and Development (2023) Vol. 45, Iss. 5, pp. 260-269
Closed Access | Times Cited: 7
Sujuan Sun, Xiangliang Li, Xuewu Liu
Brain and Development (2023) Vol. 45, Iss. 5, pp. 260-269
Closed Access | Times Cited: 7
Antiseizure Medication-Induced Alopecia: A Literature Review
Jamir Pitton Rissardo, Ana Letícia Fornari Caprara, Maritsa Casares, et al.
Medicines (2023) Vol. 10, Iss. 6, pp. 35-35
Open Access | Times Cited: 7
Jamir Pitton Rissardo, Ana Letícia Fornari Caprara, Maritsa Casares, et al.
Medicines (2023) Vol. 10, Iss. 6, pp. 35-35
Open Access | Times Cited: 7
Effectiveness, safety and tolerability of perampanel by age group when used to treat people with focal and generalized epilepsy in clinical practice: The PERMIT Extension study
James W. Wheless, Robert Wechsler, Patricia Penovich, et al.
Epilepsy & Behavior (2023) Vol. 147, pp. 109369-109369
Open Access | Times Cited: 7
James W. Wheless, Robert Wechsler, Patricia Penovich, et al.
Epilepsy & Behavior (2023) Vol. 147, pp. 109369-109369
Open Access | Times Cited: 7
Perampanel in real-world clinical care of adolescent and adult patients with epilepsy: Results from the retrospective Phase IV PROVE Study
Eric Segal, James W. Wheless, Katherine Moretz, et al.
Seizure (2022) Vol. 98, pp. 87-94
Open Access | Times Cited: 11
Eric Segal, James W. Wheless, Katherine Moretz, et al.
Seizure (2022) Vol. 98, pp. 87-94
Open Access | Times Cited: 11
Efficacy and tolerability of perampanel in pediatric patients with Dravet syndrome
Osama Y. Muthaffar, Ahmed K. Bamaga, Anas S. Alyazidi, et al.
Translational Pediatrics (2024) Vol. 13, Iss. 4, pp. 584-595
Open Access | Times Cited: 2
Osama Y. Muthaffar, Ahmed K. Bamaga, Anas S. Alyazidi, et al.
Translational Pediatrics (2024) Vol. 13, Iss. 4, pp. 584-595
Open Access | Times Cited: 2
Perampanel as monotherapy and adjunctive therapy for focal onset seizures, focal to bilateral tonic-clonic seizures and as adjunctive therapy of generalized onset tonic-clonic seizures
Ivana Tyrlíková, Milan Brázdil, Ivan Rektor, et al.
Expert Review of Neurotherapeutics (2018) Vol. 19, Iss. 1, pp. 5-16
Closed Access | Times Cited: 19
Ivana Tyrlíková, Milan Brázdil, Ivan Rektor, et al.
Expert Review of Neurotherapeutics (2018) Vol. 19, Iss. 1, pp. 5-16
Closed Access | Times Cited: 19
Efficacy and serum concentrations of perampanel for treatment of drug-resistant epilepsy in children, adolescents, and young adults: comparison of patients younger and older than 12 years
Satoru Ikemoto, Shin‐ichiro Hamano, Yuko Hirata, et al.
Seizure (2019) Vol. 73, pp. 75-78
Open Access | Times Cited: 18
Satoru Ikemoto, Shin‐ichiro Hamano, Yuko Hirata, et al.
Seizure (2019) Vol. 73, pp. 75-78
Open Access | Times Cited: 18
Use of perampanel in children with refractory epilepsy of genetic aetiology
Rui Qu, Yuanyuan Dai, Xiangju Qu, et al.
Epileptic Disorders (2022) Vol. 24, Iss. 4, pp. 687-695
Closed Access | Times Cited: 10
Rui Qu, Yuanyuan Dai, Xiangju Qu, et al.
Epileptic Disorders (2022) Vol. 24, Iss. 4, pp. 687-695
Closed Access | Times Cited: 10
Effectiveness and tolerability of adjunctive perampanel in the treatment of pediatric patients with uncontrolled epilepsy: A retrospective, single-center, real-world study
Li Gao, Lina Shi, Qianqian Liu
Epilepsy & Behavior (2022) Vol. 137, pp. 108961-108961
Open Access | Times Cited: 10
Li Gao, Lina Shi, Qianqian Liu
Epilepsy & Behavior (2022) Vol. 137, pp. 108961-108961
Open Access | Times Cited: 10
Genetics and clinical correlation of Dravet syndrome and its mimics – experience of a tertiary center in Taiwan
Yi-Hsuan Liu, Yi-Ting Cheng, Meng‐Han Tsai, et al.
Pediatrics & Neonatology (2021) Vol. 62, Iss. 5, pp. 550-558
Open Access | Times Cited: 13
Yi-Hsuan Liu, Yi-Ting Cheng, Meng‐Han Tsai, et al.
Pediatrics & Neonatology (2021) Vol. 62, Iss. 5, pp. 550-558
Open Access | Times Cited: 13
Effectiveness and tolerability of perampanel monotherapy in children with newly diagnosed focal epilepsy
Fen Zhao, Ying Ren, Guifu Geng, et al.
Frontiers in Neurology (2023) Vol. 14
Open Access | Times Cited: 5
Fen Zhao, Ying Ren, Guifu Geng, et al.
Frontiers in Neurology (2023) Vol. 14
Open Access | Times Cited: 5
Role of Perampanel in the Management of Pediatric Epilepsies in Asia: Expert Opinion
Wang‐Tso Lee, Derrick Chan, Sheffali Gulati, et al.
Pediatric Neurology (2023) Vol. 151, pp. 5-16
Open Access | Times Cited: 5
Wang‐Tso Lee, Derrick Chan, Sheffali Gulati, et al.
Pediatric Neurology (2023) Vol. 151, pp. 5-16
Open Access | Times Cited: 5
Effectiveness and safety of perampanel in Chinese paediatric patients (2‐14 years) with refractory epilepsy: a retrospective, observational study
Rui Qu, Yuanyuan Dai, Xuqin Chen, et al.
Epileptic Disorders (2021) Vol. 23, Iss. 6, pp. 854-864
Closed Access | Times Cited: 12
Rui Qu, Yuanyuan Dai, Xuqin Chen, et al.
Epileptic Disorders (2021) Vol. 23, Iss. 6, pp. 854-864
Closed Access | Times Cited: 12
